NCT01024517

GLPG0259 Solid Formulation Bioavailability and Food Effect

An Open Label Study to Compare the Oral Bioavailability of a Solid Dose Formulation of GLPG0259 Relative to an Oral Solution After Single-dose Intake in Healthy Subjects and to Evaluate the Effect of Food on the Solid Dose Formulation.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Galapagos NV · Industry
• Sex: Male
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to compare the pharmacokinetics of GLPG0259 as a solid dosage formulation (with and without food)and an oral solution, and to assess its safety and tolerability.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	GLPG0259 solution	single oral dose, GLPG0259, 50 mg oral solution
DRUG	GLPG0259	single oral dose, GLPG0259, 50 mg solid formulation

Timeline

• Start date: 2009-11-01
• Primary completion: 2009-12-01
• Completion: 2010-02-01
• First posted: 2009-12-02
• Last updated: 2010-04-27

Locations

1 site across 1 country: Belgium